[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-345271-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-345271-en":131},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","testing-interventions-to-increase-participation-in-the-national-bowel-cancer-screening-program-among-persistent-never-screeners-study-protocol-for-a-randomised-controlled-trial","Testing interventions to increase participation in the National Bowel Cancer Screening Program among persistent never-screeners: study protocol for a randomised controlled trial","","Bowel cancer screening using faecal immunochemical tests (FIT) can detect early cancer and pre-cancerous adenoma, enabling earlier diagnosis and treatment to reduce morbidity and mortality. In Australia’s National Bowel Cancer Screening Program (NBCSP), only 42% of eligible 50–74-year recipients return free FIT kits every two years. People aged 45–49 must request kits and lack participation data. ‘Persistent never-screeners’—receiving at least three NBCSP kits without return—are targeted by this randomized controlled trial.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/testing-interventions-to-increase-participation-in-the-national-bowel-cancer-screening-program-among-persistent-never-screeners-study-protocol-for-a-randomised-controlled-trial/345271/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/testing-interventions-to-increase-participation-in-the-national-bowel-cancer-screening-program-among-persistent-never-screeners-study-protocol-for-a-randomised-controlled-trial/345271.png","ImageObject",300,407,{"name":42,"@type":43},"Liam","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-30","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",11,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What problem does the study address in Australia’s bowel cancer screening program?","Question",{"text":63,"@type":64},"The program mails free FIT kits, but only about 42% are returned. Some eligible people never participate even after multiple invitations.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"Who qualifies as a “persistent never-screener” for this trial?",{"text":68,"@type":64},"Participants are people who have received at least three NBCSP kits but have never returned any of them, and who are due for pre-invitation letters during the trial period.",{"name":70,"@type":61,"acceptedAnswer":71},"How will the trial test whether invitation materials improve screening participation?",{"text":72,"@type":64},"Eligible participants will be randomly assigned to one of three arms over a 5-week enrollment period and followed for 6 months, comparing kit return between two intervention arms and a control arm.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},345271,1790194541,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,127],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":124,"doc_module":4,"doc_module_name":25,"category_name":125,"show_sort_weight":124,"slug":126},10,"Lifestyle","lifestyle",{"id":128,"doc_module":4,"doc_module_name":25,"category_name":129,"show_sort_weight":97,"slug":130},19,"General","general",{"code":4,"msg":82,"data":132},{"doc_id":79,"user_id":133,"nickname":42,"user_avatar":134,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":140,"language":141,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":12,"update_tm":145,"read_time":146,"preview_page_count":33,"preview_urls":147},8796095461564,"https://ap-avatar.wpscdn.com/davatar_155a257f0dc6eb9ab79c44ca47cae57d","McIntosh et al. Trials (2026) 27:329  \n[https://doi.org/10.1186/s13063-026-09553-2](https://doi.org/10.1186/s13063-026-09553-2)  \nTrials  \n STUDY PROTOCOL Open Access  \nTesting interventions to increase  \nparticipation in the Australian National Bowel Cancer Screening Program among persistent never-screeners: study protocol  \nfor a randomised controlled trial  \nJennifer G McIntosh1,2* , Belinda Goodwin3, Driss Ait Ouakrim1, Katelyn Collins3, Carlene Wilson1, Nancy N. Baxter4, Joyce Jiang1, Robert K. Mahar5,6, Louisa Flander1, Jon D Emery2,7, Shanton Chang8, Natalie Taylor9, Eleonora Feletto10, Jie-Bin Lew 10, Karen Canfell10, Finlay Macrae11, Harry Greenwell12 and Mark Jenkins1  \nAbstract  \nBackground Bowel cancer screening using faecal immunochemical tests (FIT) can detect early signs of bowel cancer and pre-cancerous adenoma. Early detection enables early diagnosis and treatment thereby reducing associated morbidity and mortality from bowel cancer. The National Bowel Cancer Screening Program (NBCSP) in Australia mails free FIT kits to eligible people aged 50–74 every 2 years; currently, only 42% of people return their kits. People aged 45–49 are eligible but need to request their kit, and as this has been recently introduced, participation data are not yet available. Many people never participate despite multiple invitations; ‘persistent never screeners’ are defined as people who have received at least three NBCSP kits but never returned any. This trial aims to increase screening participation among persistent never screeners by modifying invitation materials.  \nMethods Eligible participants (persistent never screeners due for pre-invitation letters) will be randomly assigned to one of three trial arms over a 5-week enrolment period and followed up for 6 months. The trial will compare kit return between two intervention arms and a control arm to determine effectiveness.  \nTrial participants Individuals who are defined as persistent never screeners are eligible for the NBCSP and are due for a pre-invitation letter during the trial period.  \n*Correspondence:  \nJennifer G McIntosh  \n[jennifer.mcintosh@unimelb.edu.au](jennifer.mcintosh@unimelb.edu.au)  \nFull list of author information is available at the end of the article  \n© The Author(s) 2026. Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit [http://creativecommons.org/licenses/by-nc-nd/4.0/](http://creativecommons.org/licenses/by-nc-nd/4.0/.)[.](http://creativecommons.org/licenses/by-nc-nd/4.0/.)  \nMcIntosh et al. Trials (2026) 27:329 Page 2 of 15  \nInterventions  \n1. A modified pre-invitation letter will be sent identifying that they have not yet screened with the program and that they are not up to date with their screening. It will highlight that they are at increased risk of bowel cancer and provide a QR code and weblink to a site that allows them to order a NBCSP kit.  \n2. A kit with revised invitation materials, including:  \n• a modified letter highlighting increased risk from not completing previous kits,  \n• a QR code linking to information addressing common scr","cbCaioOjxCL4NGZ6","https://ap.wps.com/l/cbCaioOjxCL4NGZ6","pdf",1847041,15,"English","# Abstract\n# Background\n# Methods\n## Trial arms and follow-up\n# Trial participants\n# Interventions\n## Modified pre-invitation letter\n## Revised invitation materials\n# Control\n# Discussion\n# Keywords","[{\"question\":\"What problem does the study address in Australia’s bowel cancer screening program?\",\"answer\":\"The program mails free FIT kits, but only about 42% are returned. Some eligible people never participate even after multiple invitations.\"},{\"question\":\"Who qualifies as a “persistent never-screener” for this trial?\",\"answer\":\"Participants are people who have received at least three NBCSP kits but have never returned any of them, and who are due for pre-invitation letters during the trial period.\"},{\"question\":\"How will the trial test whether invitation materials improve screening participation?\",\"answer\":\"Eligible participants will be randomly assigned to one of three arms over a 5-week enrollment period and followed for 6 months, comparing kit return between two intervention arms and a control arm.\"}]","Testing interventions to increase participation in the National Bowel Cancer Screening Program among persistent never-screeners: study protocol for a randomised controlled trial | PDF",1790057055,38,[148,152,156,160],{"page_no":22,"url":149,"width":150,"height":151},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/17de7aba161486ed25bb367b0d744f42.webp",983,1305,{"page_no":26,"url":153,"width":154,"height":155},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b380156fc8ca488f72534e10395b6fe0.webp",982,1304,{"page_no":30,"url":157,"width":158,"height":159},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/8d58ceba46eb3b207999247fd22215b4.webp",981,1303,{"page_no":33,"url":161,"width":162,"height":163},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/8daa046fabdaca92bb6c8db299ada59e.webp",980,1301]